Neil Stahl, SVP Research and Development S at REGENERON PHARMACEUTICALS INC (REGN), sold 23,354 shares at $340.39 ($7.9M) on 2014-08-07, disclosed to the SEC on 2014-08-08.
Open-market sale of $7.9M REGN by SVP Research and Development S. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $336.11 | 2,212 | $743K | 9.5% |
| 2 | $336.11 | 18,301 | $6.2M | 78.2% |
| 3 | $340.39 | 624 | $212K | 2.7% |
| 4 | $341.03 | 117 | $40K | 0.5% |
| 5 | $340.60 | 1,900 | $647K | 8.2% |
| 6 | $341.00 | 200 |
| $68K |
| 0.9% |
| Total | $336.66 avg | 23,354 | $7.9M | 100% |
| Filing → |
| REGN | SELL | 2023-08-23 | $19.6M | — | Filing → |
| REGN | SELL | 2022-08-08 | $28.4M | — | Filing → |
| REGN | SELL | 2021-05-18 | $18.2M | — | Filing → |